Abbott India Ltd (ABBOTINDIA)

Abbott India Ltd (ABBOTINDIA) is listed on the NSE in the Healthcare sector, Pharmaceuticals & Biotechnology industry. Market capitalisation: 59880.64 Cr. Figures below are as reported and are shown with their source and date.

Educational use only — GoQuant is a research tool. This page lists company facts only and is not a recommendation. Investment advice is provided by FINOME TECHNOLOGIES PVT LTD (AltQube), SEBI-registered Investment Adviser, registration no. INA000018373, under a signed advisory agreement and after a risk profile. Past performance is not indicative of future results.

Company profile

Sector
Healthcare
Industry
Pharmaceuticals & Biotechnology
Market cap (₹ Cr)
59,880.64

Abbott India Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 3,700 full-time employees. The firm has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. The company provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolics, multi-specialty, vaccines and consumer health, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremalax (constipation), Pankreoflat (indigestion) and Duvadilan (preterm labor), among others. The company offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna, among others.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 25,360

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E
34.72
52-week high
30,655
52-week low
25,135
Revenue CAGR, 3 years (%)
9.01
Revenue CAGR, 5 years (%)
9.96
EPS CAGR, 3 years (%)
17.8
EPS CAGR, 5 years (%)
17.58

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Year endedRevenue (₹ Cr)PAT (₹ Cr)EPS (₹)
Mar 20266,929.051,552.02730.39
Mar 20256,409.151,414.44665.64
Mar 20245,848.911,201.22565.3
Mar 20235,348.73949.41446.8
Mar 20224,919.27798.7375.87

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter
74.99%
FII
0.26%
DII
8.93%
Public
15.81%
Promoter shares pledged
0%

Source: finedge · as of 2026-03-31

Similar companies

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does Abbott India Ltd do?
Abbott India Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 3,700 full-time employees. The firm has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. The company provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolics, multi-specialty, vaccines and consumer health, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremalax (constipation), Pankreoflat (indigestion) and Duvadilan (preterm labor), among others. The company offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna, among others.
Which sector is Abbott India Ltd in?
Abbott India Ltd is in the Healthcare sector, Pharmaceuticals & Biotechnology industry.
What are Abbott India Ltd's latest annual revenue and profit?
For the year ended Mar 2026: revenue 6929.05 Cr, profit after tax 1552.02 Cr.
What is the promoter holding and pledge in Abbott India Ltd?
Promoter holding is 74.99%; pledged shares are 0.00% of the promoter holding.
Which companies are similar to Abbott India Ltd?
Companies in the same sector of similar size: Anthem Biosciences Ltd, Acutaas Chemicals Ltd.
Want more history and detail? Create a free account for the full price history, quarterly statements, balance sheet and cash flow.

Figures computed 2026-10-23.